Tidal Investments LLC decreased its holdings in Cronos Group Inc. (NASDAQ:CRON - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,884,980 shares of the company's stock after selling 141,509 shares during the period. Tidal Investments LLC owned about 1.28% of Cronos Group worth $9,868,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of CRON. Jones Financial Companies Lllp lifted its holdings in Cronos Group by 64.5% in the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company's stock valued at $34,000 after acquiring an additional 6,520 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of Cronos Group by 140.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after purchasing an additional 8,019 shares during the period. Kerrisdale Advisers LLC boosted its holdings in shares of Cronos Group by 2.3% in the fourth quarter. Kerrisdale Advisers LLC now owns 468,786 shares of the company's stock worth $947,000 after buying an additional 10,539 shares during the last quarter. Thompson Davis & CO. Inc. bought a new stake in Cronos Group during the fourth quarter valued at approximately $29,000. Finally, SBI Securities Co. Ltd. bought a new stake in Cronos Group during the fourth quarter valued at approximately $30,000. Institutional investors own 8.71% of the company's stock.
Cronos Group Trading Down 1.0%
NASDAQ CRON traded down $0.02 during trading hours on Friday, hitting $2.03. 1,292,536 shares of the company's stock traded hands, compared to its average volume of 1,299,280. The business's fifty day moving average price is $1.85 and its two-hundred day moving average price is $1.94. The firm has a market capitalization of $782.38 million, a P/E ratio of -15.62, a P/E/G ratio of 1.74 and a beta of 1.06. Cronos Group Inc. has a 52 week low of $1.60 and a 52 week high of $2.69.
Cronos Group (NASDAQ:CRON - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The company had revenue of $33.62 million during the quarter, compared to analyst estimates of $45.44 million. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 2.56%. On average, sell-side analysts expect that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.
Cronos Group Company Profile
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
